Arch Therapeutics Inc (ARTH)

[Polyphemus]

It's not a question of being negative, but investing or holding in an environment in which management refuses to say very much in writing is not easy. Even the recent 8-K is deliberately ambiguous: ".... The Company intends to use the net proceeds from the 2019 Financing primarily for working capital and general corporate purposes, and has not allocated specific amounts of any such remaining net proceeds from this 2019 Financing for any specific purposes.".....Does anyone have experience with a start-up company that has a FDA clearance for its only device that the company does not introduce in the US, but waits instead for a CE mark to first commercialize the device in Europe? And then raise money for no specific purpose? A declining stock price is not necessarily a sign to seize the opportunity to add to a position.